Potassium Hydroxide → HCID 70187003, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:13]=[CH:12][C:11]([CH2:14][CH:15]3[CH2:20][NH:19][CH2:18][CH2:17][N:16]3[CH2:21][CH2:22][CH2:23][CH2:24][CH2:25][CH2:26][S:27]([NH2:30])(=[O:29])=[O:28])=[CH:10][CH:9]=2)=[CH:4][CH:3]=1.[K:31].[OH-].[K+].CC(C)([O-])C.[K+]>>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:9]=[CH:10][C:11]([CH2:14][CH:15]3[CH2:20][NH:19][CH2:18][CH2:17][N:16]3[CH2:21][CH2:22][CH2:23][CH2:24][CH2:25][CH2:26][S:27]([NH2:30])(=[O:29])=[O:28])=[CH:12][CH:13]=2)=[CH:4][CH:3]=1.[K:31]Participants
5
Procedure
6-[[4-(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]hexylsulfonamide prepared according to Method A is converted into potassium salt using aqueous potassium hydroxide solution or potassium tert-butoxide and recrystallized from methanol-diethyl ether to give the title compound as colorless crystals.
Workup
- customrecrystallized from methanol-diethyl ether
Sources & evidence
- ORD record
- ord-41002b82ab4649398a63864727a49496
- Source dataset
- uspto-grants-1998_02
- Patent number
- US05716950
Reaction notes
Loading…